EOLS Slumps On Stock Offering, BLCM CFO To Exit, NVRO Trims Revenue Outlook

Today's Daily Dose brings you news about the resignation of Bellicum Pharma's CFO; Evolus' stock offering; Nevro's preliminary revenue figures for the second quarter of 2018 and full year outlook; FDA clearance of Quidel's new test and Spero's BARDA funding.

from RTT - Biotech https://ift.tt/2JtJfbh
via IFTTT